T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients

Autoimmunity

Volumn 45, Issue 2, 2012, Pages 153-160

  Oshima, Minako ^a   Deitiker, Philip R ^a   Glenn Smith, R ^b   Mosier, Dennis ^a,c   Zouhair Atassi, M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acetylcholine receptor; Myasthenia gravis; Seronegative; Synthetic peptides; T cells

Indexed keywords

CHOLINERGIC RECEPTOR; HLA DQ ANTIGEN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE; MALE; MOLECULAR RECOGNITION; MONITORING; MYASTHENIA GRAVIS; T LYMPHOCYTE;

ADULT; AGED; ALLELES; AMINO ACID SEQUENCE; AUTOANTIBODIES; AUTOIMMUNITY; FEMALE; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; PEPTIDES; RECEPTORS, CHOLINERGIC; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84856463642     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2011.611550     Document Type: Article

References (31)

1. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976;26:1054-1059.
2. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002;2:797-804. (Pubitemid 37328719)
3. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 2967 diagnostic assays. J Neurol Nuerosurg Psychiatry 1985;48:1246-1252. (Pubitemid 16229407)
4. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-368. (Pubitemid 32224355)
5. Oh SJ. Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status. J Clin Neurol 2009; 5:53-64.
6. Muppidi S,Wolfe GI. Muscle-specific receptor tyrosine kinase antibody positive and seronegative myasthenia gravis. Front Neurol Neurosci 2009;26:109-119.
7. Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008;131:1940-1952. (Pubitemid 351957451)
8. Hohlfeld R, Toyka KV, Tzartoss SJ, Carson W, Conti- Tronconi B. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor a subunit. Proc Natl Acad Sci USA 1987;84:5379-5383. (Pubitemid 17119125)
9. Oshima M, Ashizawa T, Pollack MS, Atassi MZ. Autoimmune T cell recognition of human acetylcholine receptor: The sites of T cell recognition in myasthenia gravis on the extracellular part of the a subunit. Eur J Immunol 1990;20:2563-2569.
10. Oshima M, Deitiker PR, Mosier DR, Smith RG, Atassi MZ. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human AChR a-chain peptides: Analysis in relation to age, thymic abnormality and ethnicity. Hum Immunol 2005;66:32-42. (Pubitemid 40037709)
11. Karni A, Zisman E, Katz-Levy Y, Paas-Rozner M, Dayan M, Brautbar C, Abramsky O, Sela M, Mozes E. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor. Neurology 1997;48:1638-1642.
12. Deitiker PR, Oshima M, Smith RG, Mosier DR, Atassi MZ. Subtle differences in HLA DQ haplotype-associated presentation of AChR a-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity 2006;39:277-288. (Pubitemid 44203504)
13. Mulac-Jericevic B, Manshouri T, Yokoi T, Atassi MZ. The regions of a-neurotoxin binding on the extracellular part of the a-subunit of human acetylcholine receptor. J Protein Chem 1988;7:173-177.
14. Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB, Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.
15. Pera C, Delfino L, Longo A, Pistillo MP, Ferrara GB. Novel associations among HLA-DQA1 and -DQB1 alleles, revealed by high-resolution sequence-based typing (SBT). Tissue Antigens 2000;55:275-279. (Pubitemid 30150950)
16. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993;41:119-134. (Pubitemid 23139836)
17. Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, Fernandez-Vina M, New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 2003 62 296-307. (Pubitemid 37204584)
18. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Human Immunol 2007;68:779-788. (Pubitemid 47379974)
19. Deitiker PR, Oshima M, Smith RG, Mosier D, Atassi MZ. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States. Int J Immunogenet 2011;38:55-62
20. Deitiker PR, Oshima M, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1 0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity 2010;44:167-176.
21. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, New Jersey: Prentice Hall 1996.
22. Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti- Tronconi B, Toyka KV. Myasthenia gravis: Stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology 1986;36:618-621. (Pubitemid 16074229)
23. Ofosu-Appiah W, Mokhtarian F, Shirazian D, Grob D. Production of anti-acetylcholine receptor-a antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: Role of immunoregulatory T cells and monocytes. J Lab Clin Med 1994;124:231-241. (Pubitemid 2134316)
24. Rosenberg JS, Oshima M, Atassi MZ. B-cell activation in vitro by helper T cells specific to region a146-162 of Torpedo californica nicotinic acetylcholine receptor. J Immunol 1996; 157:3192-3199. (Pubitemid 126450083)
25. Wang ZY, Okita DK, Howard JF, Conti-Fine BM. Th1 cells of myasthenia gravis patients recognize multiple epitopes on the muscle acetylcholine receptor a subunit. Ann NY Acad Sci 1998;841:329-333. (Pubitemid 28362860)
26. Willcox N, Schluep M, Ritter MA, Newsom-Davis J. The thymus in seronegative myasthenia gravis patients. J Neurol 1991;238:256-261.
27. Atassi MZ, Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008;41:123-132. (Pubitemid 351372294)
28. Baggi F, Antozzi C, Andreetta F, Confaloniri P, Ciusani E, Begovich AB, Erlich HA, Cornelio A, Mantegazza R. Identification of a novel HLA class II association with DQB1 0502 in an Italian myasthenic population. Ann NY Acad Sci 1998;841:355-359.
29. Yousefipour GA, Salami Z, Farjadian S. Association of HLADQA1 0101/2 and DQB1 0502 with myasthenia gravis in southern Iranian patients. Iran J Immunol 2009;6:99-102.
30. Saruhan-Direskeneli G, Kilic A, Parman Y, Serdaroglu P, Deymeer F. HLA-DQ polymorphism in Turkish patients with myasthenia gravis. Hum Immunol 2006;67:352-358. (Pubitemid 43729355)
31. Hayashi A, Shiono H, Ohta M, Ohta K, Okumura M, Sawa Y. Heterogeneity of immunopathological features of AChR/ MuSK autoantibody-negative myasthenia gravis. J Neuroimmunol 2007;189:163-168. (Pubitemid 47379436)